CRISPR Therapeutics AG (CRSP)
NASDAQ: CRSP · Real-Time Price · USD
52.10
+0.25 (0.49%)
Jun 8, 2026, 11:21 AM EDT - Market open
CRISPR Therapeutics AG Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| William Blair | William Blair | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Jun 4, 2026 |
| Bank of America Securities | Bank of America Securities | Buy Maintains $83 | Buy | Maintains | $83 | +59.32% | May 14, 2026 |
| Bernstein | Bernstein | Hold Reiterates $50 → $56 | Hold | Reiterates | $50 → $56 | +7.50% | May 13, 2026 |
| Evercore ISI | Evercore ISI | Buy Maintains $74 → $76 | Buy | Maintains | $74 → $76 | +45.89% | May 11, 2026 |
| Citi | Citi | Buy Reiterates $80 → $82 | Buy | Reiterates | $80 → $82 | +57.40% | May 7, 2026 |
| Wells Fargo | Wells Fargo | Hold Maintains $75 | Hold | Maintains | $75 | +43.97% | May 6, 2026 |
| RBC Capital | RBC Capital | Hold Maintains $50 | Hold | Maintains | $50 | -4.02% | May 5, 2026 |
| Piper Sandler | Piper Sandler | Buy Reiterates $110 | Buy | Reiterates | $110 | +111.15% | May 5, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.